Margot (Drospirenone, Ethinylestradiol)

The combination suppresses the mid‑cycle surge of luteinising hormone (LH) and follicle‑stimulating hormone (FSH), which stops ovulation. Drospirenone thickens cervical mucus and alters the endometrium, while ethinylestradiol stabilises the uterine lining, together reducing the chance of fertilisation and implantation.

The dosing regimen for Margot is determined by the prescribing healthcare professional. Typically, it is taken as one tablet daily at the same time each day, but the exact schedule and any missed‑dose instructions should follow the prescriber’s guidance.

Margot is contraindicated during pregnancy and should be stopped if pregnancy occurs. Its safety during breastfeeding has not been established; healthcare providers usually advise alternative contraception for nursing mothers.

To order Margot, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Margot contains drospirenone, a progestin with anti‑androgenic and mild diuretic properties, which may offer benefits such as reduced water retention and acne improvement compared with some other progestins. Efficacy in preventing pregnancy is comparable across approved combined oral contraceptives.

Store Margot tablets at room temperature, below 25 °C. Keep them in the original blister pack, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain tablet integrity.

Margot is taken orally as a tablet. The usual practice is to swallow one tablet each day, preferably at the same time, with or without food, following the prescriber’s instructions for the start of a new pack.

Serious risks include venous or arterial thromboembolism, hypertension, liver disorders, and severe allergic reactions. Women with a history of blood clots, smoking over 15 cigarettes per day after age 35, or certain cardiovascular conditions should discuss these risks with their healthcare provider.

Margot should not be used by women who are pregnant, have known or suspected breast cancer, have a history of thromboembolic disorders, uncontrolled hypertension, severe liver disease, or who are smokers over the age of 35. Contraindications must be confirmed by a qualified prescriber.